Sleep Apnea Clinical Trial
— MitralHDZOfficial title:
Echocardiographic Parameter and Sleep Apnea Changes After Mitral Valve Surgery
| Verified date | March 2017 |
| Source | Heart and Diabetes Center North-Rhine Westfalia |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The investigators evaluate the changes of echocardiographic and sleep apnea parameters after mitral valve surgery. The patients undergo echocardiographic and sleep apnea control before surgery. After a period of 3-5 months, they undergo a second echocardiographic and sleep apnea control and the results are evaluated.
| Status | Completed |
| Enrollment | 132 |
| Est. completion date | March 1, 2017 |
| Est. primary completion date | May 2015 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - mitral valve defect - NYHA II-IV - no additional cardiac surgical procedure Exclusion Criteria: - Pregnancy - lung disease - regular follow-up in the study Center in the first 6 months after surgery not guaranteed - congenital heart disease |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Heart and Diabetes Center North Rhine-Westphalia | Bad Oeynhausen |
| Lead Sponsor | Collaborator |
|---|---|
| Zisis Dimitriadis |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes of left ventricular systolic function | 1-4 weeks before and 3 months after surgery | ||
| Primary | Changes of apnea-hypopnea index | 1-4 weeks before and 3 months after surgery | ||
| Primary | Changes of global longitudinal strain | 1-4 weeks before and 3 months after surgery | ||
| Primary | Changes of right ventricular systolic function | 1-4 weeks before and 3 months after surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
| Recruiting |
NCT03919955 -
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
|
Phase 2 | |
| Completed |
NCT03927547 -
Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders
|
N/A | |
| Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
| Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
| Completed |
NCT01503164 -
Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
|
N/A | |
| Recruiting |
NCT00747890 -
Surgical Treatment of Mild Obstructive Sleep Apnea
|
N/A | |
| Active, not recruiting |
NCT00738179 -
Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease
|
Phase 3 | |
| Completed |
NCT00841906 -
Alice PDx User/Validation Extended Trial
|
N/A | |
| Completed |
NCT00202501 -
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome
|
N/A | |
| Completed |
NCT00047463 -
Effects of Treating Obstructive Sleep Apnea in Epilepsy
|
Phase 2 | |
| Not yet recruiting |
NCT06029881 -
Portable System for Non-intrusive Monitoring of Sleep
|
||
| Recruiting |
NCT06093347 -
Central Apnoea Monitor Study
|
||
| Terminated |
NCT05445869 -
Severe OSA Study (SOS)
|
N/A | |
| Withdrawn |
NCT04096261 -
The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
|
||
| Recruiting |
NCT04575740 -
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
|
N/A | |
| Completed |
NCT04676191 -
Validation of a Contactless Vital Signs Measurement Sensor
|
N/A | |
| Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
| Completed |
NCT06051097 -
Metabolic Syndrome and Obstructive Sleep Apnea
|
||
| Completed |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|